OneSource™ one-on-one patient support can help you understand your insurance benefits, provide gMG education, and more. Plus view or download useful tools and information, and explore other recommended websites.
OneSource Case Managers have anti-AChR Ab+ gMG disease education and health insurance expertise. One will be assigned to you to provide complimentary one-on-one education and support. You may also contact your OneSource Case Manager to request a gMG Treatment Journal to use along your journey.
Know which questions to ask and topics to bring up when discussing your gMG symptoms with your doctor.
Measure the severity of your gMG symptoms—such as talking, chewing, swallowing, and breathing—and their impact on your daily activities.
Prepare yourself with valuable treatment tips and information for getting started on Soliris.
Keep track of your infusion schedule, record your symptoms during treatment, get useful tips for taking on your day, and more. Contact your OneSource Case Manager to request a gMG Treatment Journal, or an additional journal if you are almost done with the one you have.
Your doctor will give you a Patient Safety Card about the risk of meningococcal infection. Carry it with you at all times during treatment and for 3 months after your last Soliris dose. Your risk of meningococcal infection may continue for several weeks after your last dose of Soliris. It is important to show this card to any doctor or nurse who treats you. This will help them diagnose and treat you quickly.
Together with your doctor, use this chart to understand which vaccines are needed before starting Soliris so you can help reduce your risk of meningococcal infections during treatment.
Provides information, support, and additional gMG assessment tools to people with gMG and their loved ones. Visit myasthenia.org.
Up-to-date news, information, and stories about life with gMG. Visit myastheniagravisnews.com.
Helps children and adults with neuromuscular diseases through research. Visit mda.org.
Provides advocacy and education to improve the lives of those affected by rare diseases. Visit rarediseases.org.
One of the world’s leading rare disease patient advocacy organizations. Visit globalgenes.org.
Sign up to get the latest news and information about anti-AChR Ab+ gMG and Soliris to help you make the most of your treatment.
Sign up nowSOLIRIS is a medicine that affects your immune system. SOLIRIS can lower the ability of your immune system to fight infections.
Your doctor will give you a Patient Safety Card about the risk of meningococcal infection. Carry it with you at all times during treatment and for 3 months after your last SOLIRIS dose. Your risk of meningococcal infection may continue for several weeks after your last dose of SOLIRIS. It is important to show this card to any doctor or nurse who treats you. This will help them diagnose and treat you quickly.
SOLIRIS is only available through a program called the SOLIRIS REMS. Before you can receive SOLIRIS, your doctor must:
SOLIRIS may also increase the risk of other types of serious infections. Certain people may be at risk of serious infections with gonorrhea. Talk to your doctor about whether you are at risk for gonorrhea infection, about gonorrhea prevention, and regular testing. Certain fungal infections (Aspergillus) may also happen if you take SOLIRIS and have a weak immune system or a low white blood cell count.
Do not receive SOLIRIS if you:
Before you receive SOLIRIS, tell your doctor about all of your medical conditions, including if you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. SOLIRIS and other medicines can affect each other causing side effects.
It is important that you:
Know the medications you take and the vaccines you receive. Keep a list of them to show your doctor and pharmacist when you get a new medicine.
SOLIRIS can cause serious side effects including:
If you have an allergic reaction to SOLIRIS, your doctor may need to infuse SOLIRIS more slowly, or stop SOLIRIS. See “How will I receive SOLIRIS?” in the Medication Guide.
The most common side effects in people with gMG treated with SOLIRIS include:
Tell your doctor about any side effect that bothers you or that does not go away. These are not all the possible side effects of SOLIRIS. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.
SOLIRIS is a prescription medicine called a monoclonal antibody. SOLIRIS is used to treat:
It is not known if SOLIRIS is safe and effective in children with gMG.
Please see the full Prescribing Information and Medication Guide for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections.
SOLIRIS is a medicine that affects your immune system. SOLIRIS can lower the ability of your immune system to fight infections.
Your doctor will give you a Patient Safety Card about the risk of meningococcal infection. Carry it with you at all times during treatment and for 3 months after your last SOLIRIS dose. Your risk of meningococcal infection may continue for several weeks after your last dose of SOLIRIS. It is important to show this card to any doctor or nurse who treats you. This will help them diagnose and treat you quickly.
SOLIRIS is only available through a program called the SOLIRIS REMS. Before you can receive SOLIRIS, your doctor must:
SOLIRIS may also increase the risk of other types of serious infections. Certain people may be at risk of serious infections with gonorrhea. Talk to your doctor about whether you are at risk for gonorrhea infection, about gonorrhea prevention, and regular testing. Certain fungal infections (Aspergillus) may also happen if you take SOLIRIS and have a weak immune system or a low white blood cell count.
Do not receive SOLIRIS if you:
Before you receive SOLIRIS, tell your doctor about all of your medical conditions, including if you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. SOLIRIS and other medicines can affect each other causing side effects.
It is important that you:
Know the medications you take and the vaccines you receive. Keep a list of them to show your doctor and pharmacist when you get a new medicine.
SOLIRIS can cause serious side effects including:
If you have an allergic reaction to SOLIRIS, your doctor may need to infuse SOLIRIS more slowly, or stop SOLIRIS. See “How will I receive SOLIRIS?” in the Medication Guide.
The most common side effects in people with gMG treated with SOLIRIS include:
Tell your doctor about any side effect that bothers you or that does not go away. These are not all the possible side effects of SOLIRIS. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.
SOLIRIS is a prescription medicine called a monoclonal antibody. SOLIRIS is used to treat:
It is not known if SOLIRIS is safe and effective in children with gMG.
Please see the full Prescribing Information and Medication Guide for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections.